1. The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors
   Kacper Maciejewski et al, 2024, International Journal of Molecular Sciences CrossRef
2. HDAC7: a promising target in cancer
   Cui Liu et al, 2024, Frontiers in Oncology CrossRef
3. Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review
   Maria Debbarma et al, 2024, Medical Oncology CrossRef
4. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer
   Wei Wen et al, 2024, Clinical Breast Cancer CrossRef
5. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research
   Brittany L. Witt et al, 2023, Life CrossRef
6. Small molecule agents for triple negative breast cancer: Current status and future prospects
   Yan Ou et al, 2024, Translational Oncology CrossRef
7. The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma
   Yuanyuan Peng et al, 2025, Gene CrossRef